AI business Recursion Pharmaceuticals has narrowed its drug development pipeline, ending or pausing five programmes as it seeks to reduce costs and reprioritise resources following a merger with ...

The process should be supervised by a court-appointed official and allow the DOJ to approve or reject potential buyers “This comprehensive set of remedies…is necessary to terminate Google’s ...

On Aug. 8, Recursion Pharmaceuticals announced its intention to merge with Exscientia in an all-stock deal. Recursion Pharmaceuticals and Exscientia are both pharma-tech companies that aim to ...

Immigration officials signaled that the Trump administration would continue to pursue efforts to terminate the legal status of the students, despite a wave of legal challenges. By Zach Montague ...